SCHEMBL10839348

SCHEMBL10839348

CCN(c1ccncc1)c1ccccc1C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC7 O00311 5/20 0.39
▸ SIRT3 Q9NTG7 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ IKBKB O14920 2/20 0.36
▸ CHUK O15111 1/20 0.36
▸ IKBKE Q14164 1/20 0.36
▸ PKMYT1 Q99640 1/20 0.36
▸ CCNA2 P20248 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ CCNA1 P78396 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ OPRM1 P35372 1/20 0.36
▸ OPRD1 P41143 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ ROCK2 O75116 2/20 0.36
▸ MAP4K4 O95819 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7259310 0.88 ALDH1A1 (0.44) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL10838759 0.80 HTT (0.46) KDM4EALDH1A1HPGDMAPTTSHR
SCHEMBL10836335 0.78 CYP2D6 (0.43) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL335962 0.74 MAPT (0.45) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL28773230 0.73 ALDH1A1 (0.46) KDM4EALDH1A1HPGDMAPTTSHR
SCHEMBL29129841 0.73 MAPT (0.46) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL24620298 0.71 MAPT (0.47) KDM4EALDH1A1MAPTTSHRSLC6A2
SCHEMBL7360410 0.71 CHRM5 (0.52) MAPTSLC6A2KMT2AMEN1LMNA
Salicylamide SCHEMBL28697107 0.70 KDM4E (0.59) SIRT3TDP1KDM4EALDH1A1HPGD
SCHEMBL14770852 0.70 KMT2A (0.51) KDM4EALDH1A1HSD17B10MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4610991-A Antihypertensive pyridylaminobenzamide compounds STERLING DRUG INC. (US) 1986-09-09 — — US disclosed
EP-0098951-A2 Aminobenzamide derivatives and preparation thereof STERLING DRUG INC. (US) 1984-01-25 — — EP disclosed
Send feedback